Sentences with phrase «factor structure analysis»

Second, the factor structure analysis pointed out that emotion expression is considered by upper elementary students as dysfunctional while this strategy appears among the functional strategies within the theoretical model.

Not exact matches

Part I provides a historical overview of the development of religious television in America and an analysis of the factors which have contributed to its particular structure and the issues raised by it.

The basic structures of the common life can not be grasped by class analysis alone, although Marx thought the class factor was decisive.

Ideological discomfort, investment property involvement, fear of impacting real estate values and a reliance on endless road to recovery government funding, are all factors which singly, or in combo, have kept analysis of the structure of local drug trade off the table.

These factors make structure analysis very difficult.»

Susan Amara, USA - «Regulation of transporter function and trafficking by amphetamines, Structure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) traStructure - function relationships in excitatory amino acid transporters (EAATs), Modulation of dopamine transporters (DAT) by GPCRs, Genetics and functional analyses of human trace amine receptors» Tom I. Bonner, USA (Past Core Member)- Genomics, G protein coupled receptors Michel Bouvier, Canada - Molecular Pharmacology of G protein - Coupled Receptors; Molecular mechanisms controlling the selectivity and efficacy of GPCR signalling Thomas Burris, USA - Nuclear Receptor Pharmacology and Drug Discovery William A. Catterall, USA (Past Core Member)- The Molecular Basis of Electrical Excitability Steven Charlton, UK - Molecular Pharmacology and Drug Discovery Moses Chao, USA - Mechanisms of Neurotophin Receptor Signaling Mark Coles, UK - Cellular differentiation, human embryonic stem cells, stromal cells, haematopoietic stem cells, organogenesis, lymphoid microenvironments, develomental immunology Steven L. Colletti, USA Graham L Collingridge, UK Philippe Delerive, France - Metabolic Research (diabetes, obesity, non-alcoholic fatty liver, cardio - vascular diseases, nuclear hormone receptor, GPCRs, kinases) Sir Colin T. Dollery, UK (Founder and Past Core Member) Richard M. Eglen, UK Stephen M. Foord, UK David Gloriam, Denmark - GPCRs, databases, computational drug design, orphan recetpors Gillian Gray, UK Debbie Hay, New Zealand - G protein - coupled receptors, peptide receptors, CGRP, Amylin, Adrenomedullin, Migraine, Diabetes / obesity Allyn C. Howlett, USA Franz Hofmann, Germany - Voltage dependent calcium channels and the positive inotropic effect of beta adrenergic stimulation; cardiovascular function of cGMP protein kinase Yu Huang, Hong Kong - Endothelial and Metabolic Dysfunction, and Novel Biomarkers in Diabetes, Hypertension, Dyslipidemia and Estrogen Deficiency, Endothelium - derived Contracting Factors in the Regulation of Vascular Tone, Adipose Tissue Regulation of Vascular Function in Obesity, Diabetes and Hypertension, Pharmacological Characterization of New Anti-diabetic and Anti-hypertensive Drugs, Hypotensive and antioxidant Actions of Biologically Active Components of Traditional Chinese Herbs and Natural Plants including Polypehnols and Ginsenosides Adriaan P. IJzerman, The Netherlands - G protein - coupled receptors; allosteric modulation; binding kinetics Michael F Jarvis, USA - Purines and Purinergic Receptors and Voltage-gated ion channel (sodium and calcium) pharmacology Pain mechanisms Research Reproducibility Bong - Kiun Kaang, Korea - G protein - coupled receptors; Glutamate receptors; Neuropsychiatric disorders Eamonn Kelly, Prof, UK - Molecular Pharmacology of G protein - coupled receptors, in particular opioid receptors, regulation of GPCRs by kinasis and arrestins Terry Kenakin, USA - Drug receptor pharmacodynamics, receptor theory Janos Kiss, Hungary - Neurodegenerative disorders, Alzheimer's disease Stefan Knapp, Germany - Rational design of highly selective inhibitors (so call chemical probes) targeting protein kinases as well as protein interaction inhibitors of the bromodomain family Andrew Knight, UK Chris Langmead, Australia - Drug discovery, GPCRs, neuroscience and analytical pharmacology Vincent Laudet, France (Past Core Member)- Evolution of the Nuclear Receptor / Ligand couple Margaret R. MacLean, UK - Serotonin, endothelin, estrogen, microRNAs and pulmonary hyperten Neil Marrion, UK - Calcium - activated potassium channels, neuronal excitability Fiona Marshall, UK - GPCR molecular pharmacology, structure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trastructure and drug discovery Alistair Mathie, UK - Ion channel structure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trastructure, function and regulation, pain and the nervous system Ian McGrath, UK - Adrenoceptors; autonomic transmission; vascular pharmacology Graeme Milligan, UK - Structure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) traStructure, function and regulation of G protein - coupled receptors Richard Neubig, USA (Past Core Member)- G protein signaling; academic drug discovery Stefan Offermanns, Germany - G protein - coupled receptors, vascular / metabolic signaling Richard Olsen, USA - Structure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) traStructure and function of GABA - A receptors; mode of action of GABAergic drugs including general anesthetics and ethanol Jean - Philippe Pin, France (Past Core Member)- GPCR - mGLuR - GABAB - structure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) trastructure function relationship - pharmacology - biophysics Helgi Schiöth, Sweden David Searls, USA - Bioinformatics Graeme Semple, USA - GPCR Medicinal Chemistry Patrick M. Sexton, Australia - G protein - coupled receptors Roland Staal, USA - Microglia and neuroinflammation in neuropathic pain and neurological disorders Bart Staels, France - Nuclear receptor signaling in metabolic and cardiovascular diseases Katerina Tiligada, Greece - Immunopharmacology, histamine, histamine receptors, hypersensitivity, drug allergy, inflammation Georg Terstappen, Germany - Drug discovery for neurodegenerative diseases with a focus on AD Mary Vore, USA - Activity and regulation of expression and function of the ATP - binding cassette (ABC) transporters

Based on Dr. Nelson's fundamental work, particularly in the area of molecular, cultivation - independent analysis of the structure and function of microbiomes, nowadays researchers understand the human microbiome as an important factor driving human health and investigate links between changes in microbiome structures and diseases like diabetes or obesity.

Factor analysis confirmed the multifaceted nature of teacher autonomy; however, somewhat different factor structures were found for the elementary and secondary teachers in this study, in comparison to that of FriFactor analysis confirmed the multifaceted nature of teacher autonomy; however, somewhat different factor structures were found for the elementary and secondary teachers in this study, in comparison to that of Frifactor structures were found for the elementary and secondary teachers in this study, in comparison to that of Friedman.

NDPC ‐ SD's framework provides a structured process by which SEA or LEA teams can gain sufficient knowledge to develop, sustain, and expand efforts in data analysis to (1) identify risk and protective factors; (2) identify priority areas for intervention; (3) identify and select evidence ‐ based practices to address needs; and (4) develop and implement effective programs in dropout prevention.

Persistence may be due to fixed resources, consistent industry structure, financial anomalies, price controls, or many other factors that endure... In sum, reliable inferences about the cause of persistence can not be generated from an analysis that only documents whether or not persistence occurred.

Our research organization is structured to focus fundamental analysis on the factors that matter most in global equity markets.

We thus structured our analyses to focus on those factors that are known to have a relationship to each element, tested their relationship in isolation, and then used a multi-effect model where warranted.

This presumption «goes too far in cabining how a district court must structure its analysis and what it may conclude from its review of relevant factors.»

Factors which are particularly relevant to any analysis include the structure of the relevant market (and how concentrated it is), the market power of both the seller and the buyer and the scope of the MFN clause.

For other legal studies employing factor analysis to develop composite variables, see, e.g., Ryan J. Owens & Justin P. Wedeking, Justices and Legal Clarity: Analyzing the Complexity of US Supreme Court Opinions, 45 Law & Soc» y Rev. 1027 (2011); Matthew Hiller et al., Measuring Drug Court Structure and Operations: Key Components and Beyond, 37 Crim.

• Developed various quantitative models to project the company's financial potential • Identified company's financial risk factors and implemented precautionary recommendations from time to time • Analyzed masses of unstructured data to develop structured quantitative analysis as per company requirements • Conducted extensive statistical analysis to optimize the company's stock trading

Provide structured sessions to target client crisis behavior, consulted with team to ensure DBT treatment criteria, and skillfully used behavior chain analysis to identify the contributing factors to client behavior Domestic Violence: Provide therapy to survivors of past and present domestic violence, male and female, and provide psycho education concerning power, control and the abuse cycle.

The factor structure of the WOCQ was assessed in three steps using both confirmatory factor analysis (CFA) and exploratory factor analysis (EFA).

Preliminary data analysis included EFA and CFA to determine the most appropriate factor structure for each measure.

We converged an exploratory factor analysis to test the factor structure.

An exploratory factor analysis replicated the original six - factor structure.

It would also have been useful to explore the underlying factor structure of the new scale but the small sample size restricted such an analysis.

The three - factor structure of the JIDI was confirmed by confirmatory factor analysis.

We validated the sample construction and examined the relationship between ACE items and total ACE scores (dependent variables) and important independent variables using polychoric factor analyses (designed for binary data) of the ACE survey items» factor structure.

Factor analyses of autistic traits in clinical ASD and community samples, using a variety of ASD measurement tools, generally indicate that multiple factors account for the observed covariance structure of ASD symptoms and traits (Happé and Ronald 2008; Mandy and Skuse 2008).

Structure validity of the Pittsburgh Sleep Quality Index in renal transplant recipients: A confirmatory factor analysis

A confirmatory factor analysis was run to examine if the anticipated factor structure of the items was retained across the larger pool of items and constructs, and across the wider age span of children.

Then, to test whether the a priori factor structure would fit the data of mothers and fathers, a two - group confirmatory factor analyses was conducted with all available data (missing data were not imputed; AMOS 6.0; Arbuckle, 2005).

Exploratory factor analysis (EFA) was carried out to evaluate construct validity, disclose underlying structures and reduce the number of variables of the study questionnaire.

Correlations between the individual modes and measures of general psychological distress and well - being suggest a possible two category structure which subsequent exploratory factor analysis tends to support.

Exploratory factor analysis (EFA) using principal component extraction method with Varimax rotation, was conducted to determine the factor structure of the items of the instrument (items with factor loadings ≥ 40 were retained).

The exploratory factor analysis examines the internal structure of the questionnaire and, more precisely, checks the adjustment between the data collected and the theoretical model on which the questionnaire is based (Laveault & Grégoire, 2014).

Factor analyses support the three - factor structure and studies with other style and psychological variables demonstrate the construct validity of VIEW (Burger, Marino, Ponterotto, & Houtz, 2008; Houtz, 2002; Houtz, Matos, Park, Scheinholtz, & Selby, 2007; Houtz & Selby, 2009; Houtz, Selby, Esquivel, Okoye, Peters, & Treffinger, 2003a, 2003b; Shaw, Selby, & Houtz, Factor analyses support the three - factor structure and studies with other style and psychological variables demonstrate the construct validity of VIEW (Burger, Marino, Ponterotto, & Houtz, 2008; Houtz, 2002; Houtz, Matos, Park, Scheinholtz, & Selby, 2007; Houtz & Selby, 2009; Houtz, Selby, Esquivel, Okoye, Peters, & Treffinger, 2003a, 2003b; Shaw, Selby, & Houtz, factor structure and studies with other style and psychological variables demonstrate the construct validity of VIEW (Burger, Marino, Ponterotto, & Houtz, 2008; Houtz, 2002; Houtz, Matos, Park, Scheinholtz, & Selby, 2007; Houtz & Selby, 2009; Houtz, Selby, Esquivel, Okoye, Peters, & Treffinger, 2003a, 2003b; Shaw, Selby, & Houtz, 2009).

Only one study [12] contained a factor analysis that revealed the six factor structure of the Turkish W - DEQ version B (concerns about pain, lack of positive behaviours, loneliness, lack of positive feelings, concerns about childbirth and concerns about the baby)[1].

Afterward, confirmatory factor analyses using the 11 items of the PNS - J as indicators were performed to examine whether the two - factor model — 4 items loaded on the Desire for Structure factor and the other 7 items loaded on the Response to Lack of Structure factor — fits the data better than the one - factor model.

to assess if the structure in six factors, highlighted by the exploratory factor analysis, fitted best with the data, as compared to alternative models.

In order to evaluate the factor structure an exploratory factor analysis was conducted.

The discrepancy between the internal structure highlighted by the previous analysis (6 factors) and our theoretical expectations (19 factors) is discussed later on in this paper.

In the present study, the exploratory factor analysis tests if the nineteen subscales is a valid structure for upper elementary school students, using the second sample (N = 561).

Several studies have replicated the PSC - 17's 3 - factor structure by using confirmatory factor analysis (CFA) in moderate - sized samples, 26,27 and a number of studies28 — 37 have reported on the prevalence of risk by using the overall and subscale scores.

Thus, we decided to examine the MLQ factor structure further with Confirmatory Factor Anafactor structure further with Confirmatory Factor AnaFactor Analysis.

Results CFA and reliability analysis revealed factor structures and the Cronbach alpha values of the subscales were consistent with original versions.

Under the a priori hypothesis that each scale measures a distinct latent trait, construct validity was assessed by confirmatory factor analysis (CFA) for each scale respectively, using structured equation models.

Six potential factor structures for the 18 items of the SWAN (Strengths and Weaknesses of ADHD - symptoms and Normal - behavior) scale were tested using confirmatory and exploratory factor analyses.

The parallel analysis identified three factors as the optimal solution, explaining 72 % of the total variance, and the EFA showed simple structure, with high primary loadings, and low cross-loadings.

ABSTRACT: The purpose of this study was to evaluate the structure, invariance, reliability, convergent and discriminant validity of the MLQ with exploratory and confirmatory factor analysis in 1561 Greek adults.

Peer self - concept in adolescence: Analysis of factor structure and of associations with peer experience

First two alternative models were tested using Exploratory factor analysis (EFA): 1) a standard EFA to examine the factor structure and to have a baseline model for EFA comparisons, and 2) a bifactor EFA.

Exploratory factor analyses conducted with Study 1 and Study 3 data demonstrated general consistency in the underlying factor structure of the SRLTAS and generally supported a five factor solution.

Given support for the underlying factor structure through the completely unrestricted analysis, we tested a second EFA but constrained the number of factors to 5.